Procort Cream
NDC Package 50967-357-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Procort (1.85% hydrocortisone acetate - 1.15% pramoxine hci cream) cream is this combination medication is used to treat minor pain, itching, swelling, and discomfort caused by hemorrhoids and other problems of the anal area (e.g., anal fissures, itching). This formulation utilizes a cream delivery system. Marketed by Womens Choice Pharmaceuticals Llc, this product is identified by NDC 50967-357.

Identification & Billing

NDC Package Code
50967-357-60
Package Description
1 TUBE, WITH APPLICATOR in 1 CARTON / 1 TUBE, WITH APPLICATOR in 1 TUBE, WITH APPLICATOR / 60 g in 1 TUBE, WITH APPLICATOR
Product Code
50967-357
11-Digit Billing Format
50967035760
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
60 GM
RxNorm Crosswalk
  • RxCUI: 1114854 - hydrocortisone acetate 1.85 % / pramoxine HCl 1.15 % Rectal Cream
  • RxCUI: 1114854 - hydrocortisone acetate 18.5 MG/ML / pramoxine hydrochloride 11.5 MG/ML Rectal Cream
  • RxCUI: 1115730 - ProCort 1.85 % / 1.15 % Rectal Cream
  • RxCUI: 1115730 - hydrocortisone acetate 18.5 MG/ML / pramoxine hydrochloride 11.5 MG/ML Rectal Cream [Procort 1.85/1.15]
  • RxCUI: 1115730 - Procort 1.85 % / 1.15 % (hydrocortisone acetate / pramoxine HCl) Rectal Cream

Clinical Specifications

Proprietary Name
Procort
Non-Proprietary Name
1.85% Hydrocortisone Acetate - 1.15% Pramoxine Hci Cream
Substance Name
Hydrocortisone Acetate; Pramoxine Hydrochloride
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
This combination medication is used to treat minor pain, itching, swelling, and discomfort caused by hemorrhoids and other problems of the anal area (e.g., anal fissures, itching). This medication contains pramoxine, an anesthetic that works by temporarily numbing the area. This product also contains hydrocortisone, a corticosteroid that reduces redness, itching, and swelling.

Regulatory & Marketing

Labeler Name
Womens Choice Pharmaceuticals Llc
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
06-30-2011
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50967-357-60 identifies a specific commercial package of 1 tube, with applicator in 1 carton / 1 tube, with applicator in 1 tube, with applicator / 60 g in 1 tube, with applicator of Procort, a human prescription drug labeled by Womens Choice Pharmaceuticals Llc. This product is billed per "GM" gram and contains an estimated amount of 60 billable units per package. This cream is formulated for topical use and contains hydrocortisone acetate; pramoxine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Womens Choice Pharmaceuticals Llc on June 30, 2011. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This combination medication is used to treat minor pain, itching, swelling, and discomfort caused by hemorrhoids and other problems of the anal area (e.g., anal fissures, itching). This medication contains pramoxine, an anesthetic that works by temporarily numbing the area. This product also contains hydrocortisone, a corticosteroid that reduces redness, itching, and swelling.

How is this Womens Choice Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50967035760. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50967-357-60
11-Digit CMS (5-4-2)
50967-0357-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.